{"changes":[],"country":"US","description":"Diagonal Therapeutics develops clustering antibodies that bind multiple receptors at once to regulate signaling and modify disease at its root. It targets genetic and chronic conditions like hereditary hemorrhagic telangiectasia and pulmonary hypertension. Its edge is an engine screening billions of antibody combinations to design them.","domain":"diagonaltx.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":"diagonaltx","githubStars":null,"industry":"healthtech","investors":[],"lat":52.197585,"lng":0.139154,"location":"Cambridge","name":"Diagonal Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":125000000,"currency":"USD","date":"2026-01-08","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-13","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"diagonaltx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-13","status":"attributed","url":null},{"fact":"existence","publisher":"diagonaltx.com","retrievedAt":"2026-06-13","status":"self-reported","url":"https://diagonaltx.com"},{"fact":"description","publisher":"diagonaltx.com","retrievedAt":"2026-06-13","status":"self-reported","url":"https://diagonaltx.com"}],"stage":"series-b+","techStack":["adobe fonts","hsts","netlify","next.js","react","typekit","webpack"],"totalRaisedUsd":253000000,"updatedAt":"2026-06-13"}